1000773-62-5 Usage
Description
2-(BromoMethyl)-5-(trifluoroMethyl)pyridine, a pyridine derivative with the molecular formula C8H7BrF3N, is a chemical compound that features a bromine atom and a trifluoromethyl group. This colorless to light yellow liquid with a strong odor is commonly utilized in organic synthesis and pharmaceutical research, serving as a promising intermediate in the development of new drugs and various chemical products.
Uses
Used in Pharmaceutical Research:
2-(BromoMethyl)-5-(trifluoroMethyl)pyridine is used as a key intermediate in the synthesis of pharmaceutical compounds, contributing to the development of novel drugs with potential therapeutic applications.
Used in Organic Synthesis:
In the field of organic synthesis, 2-(BromoMethyl)-5-(trifluoroMethyl)pyridine serves as a versatile building block, enabling the creation of a wide range of chemical products through its reactivity and functional groups.
Used in Chemical Production:
As an intermediate in chemical production, 2-(BromoMethyl)-5-(trifluoroMethyl)pyridine plays a crucial role in the manufacturing process of various chemicals, enhancing their properties and applications across different industries.
It is important to handle and store 2-(BromoMethyl)-5-(trifluoroMethyl)pyridine with care due to its potential hazards and reactivity, ensuring safety and optimal performance in its applications.
Check Digit Verification of cas no
The CAS Registry Mumber 1000773-62-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,0,7,7 and 3 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1000773-62:
(9*1)+(8*0)+(7*0)+(6*0)+(5*7)+(4*7)+(3*3)+(2*6)+(1*2)=95
95 % 10 = 5
So 1000773-62-5 is a valid CAS Registry Number.
1000773-62-5Relevant articles and documents
COMPOUNDS, COMPOSITIONS, AND METHODS OF USE
-
Paragraph 0304, (2020/12/11)
Described herein are compounds that act as CYP46A1 inhibitors, compositions comprising these compounds, and methods of their use into treating neurodegenerative diseases and the like, or a pharmaceutically active salt thereof. The present invention relates to compounds represented by the formula wherein each symbol is as defined in the specification, or a pharmaceutically active salt thereof.
NOVEL COMPOUNDS
-
Paragraph 0667-0668, (2015/09/22)
The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein L, X, Ra, Rb, R1, R2 and R3 are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
PYRIDONE AND PYRIDAZINONE DERIVATIVES AS MCH ANTAGONISTS
-
Page/Page column 51, (2009/10/18)
The present invention relates to pyridone and pyridazinone derivatives as listed in claim 1 including their salts. Moreover the invention relates to pharmaceutical compositions containing at least one compound according to the invention. By virtue of thei
